investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting Chromatin Modifications in Leukemia with Trisomy 21
Andrew A Lane
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew A Lane
Dana-Farber Cancer Institute
Boston, United States
Related projects
Ravi Bhatia
Microenvironmental Regulation of Leukemia Stem Cells
Leukaemia
Hematology and hematologic malignancies
Robert G Roeder
Function and targeting of a stable transcription factor complex in leukemia
Leukaemia
Michael L Cleary
Role of PGDH in leukemia pathogenesis
Leukaemia
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
Guy S Salvesen
IAP Family Proteins and Cancer
Leukaemia
Pathology
Hematology and hematologic malignancies
Mary Ellen Conley
Genetic Etiology of Agammaglobulinemia with Absent B Cells
Leukaemia
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Pathology
Hematology and hematologic malignancies
Alexander Wlodawer
Protein Structure
Leukaemia
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Pathology
Hematology and hematologic malignancies